nach oben

Erschienen in:

01.03.2007

Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors

verfasst von: Neeraj K. Arora, Ann S. Hamilton, Arnold L. Potosky, Julia H. Rowland, Noreen M. Aziz, Keith M. Bellizzi, Carrie N. Klabunde, Wendy McLaughlin, Jennifer Stevens

Erschienen in: Journal of Cancer Survivorship | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Several recent reports have recommended use of population-based cancer registries for evaluating the long-term health outcomes of cancer survivors. Drawing upon experiences from a study of survivors of non-Hodgkin’s Lymphoma (NHL), we discuss conceptual and methodological challenges to and opportunities for conducting population-based survivorship research using cancer registries.

Materials and methods

Survivors of aggressive NHL diagnosed between June 1998 and August 2001, 2–5 years prior to the study, were sampled from the Los Angeles Surveillance Epidemiology and End Results (SEER) registry. A conceptual framework was developed to systematically evaluate the association of sociodemographic, clinical, social, psychological, and behavioral factors with survivors’ health-related quality of life. Data were collected primarily by a mailed questionnaire; medical records were also abstracted.

Results

Of 744 eligible survivors identified from the registry, 181 (24.3%) were lost to follow-up; 408 responded to the questionnaire (54.8%); 155 (20.8%) refused. Those lost to follow-up included a significantly higher proportion of younger, male, and Hispanic survivors compared to the other two groups (P ≤ 0.01). There were no sociodemographic or clinical differences among the questionnaire respondents and survivors who refused study participation. Medical records were abstracted for 59.8% of the respondents. A high percentage of agreement was seen between survivors’ self-report and medical record documentation of key treatments and disease status (≥95% for survivors with complete records).

Conclusions

The cancer registry served as a valuable resource for recruiting one of the largest population-based samples of NHL survivors. The methodology and example of a conceptual framework utilized in this study provide a model for future population-based cancer survivorship research.

Affleck, G., Tennen, H., Pfeiffer, C., & Fifield, J. (1987). Appraisals of control and predictability in adapting to a chronic illness. Journal of Personality and Social Psychology, 53, 273–279.PubMedCrossRef

American Cancer Society (2006). Cancer facts and figures 2006. Atlanta, GA: American Cancer Society.

Andersen, R. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36, 1–10.PubMedCrossRef

Andre, M., Mounier, N., Leleu, X., Sonet, A., Brice, P., Henry-Amar, M., et al. (2004). Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA cohort study on 2837 patients. Blood, 103, 1222–1228.PubMedCrossRef

Ayanian, J. Z., & Jacobsen, P. B. (2006). Enhancing research on cancer survivors. Journal of Clinical Oncology, 24, 5149–5153.PubMedCrossRef

Aziz, N. M. (2006). Late effects of cancer treatments: surgery, radiation therapy, chemotherapy. Chapter 101. In A. E. Chang, P. A. Ganz, D. F. Hayes, T. Kinsella, H. I. Pass, J. H. Schiller, R. Stone, & V. Strecher (Eds.), Oncology: An evidence-based approach. Berlin Heidelberg New York: Springer.

Aziz, N. M., & Rowland, J. H. (2003). Trends and advances in cancer survivorship research: Challenge and opportunity. Seminars in Radiation Oncology, 13, 248–266.PubMedCrossRef

Baker, F., Denniston, M., Smith, T., & West, M. M. (2005). Adult cancer survivors: How are they faring? Cancer, 104(11), 2565–2576. (Suppl)PubMedCrossRef

Brennan, P., Scelo, G., Hemminki, K., Mellemkjaer, L., Tracey, E., Andersen, A., et al. (2005). Second primary cancers among 109000 cases of non-Hodgkin’s lymphoma. British Journal of Cancer, 93, 159–166.PubMedCrossRef

10.

de Haes, J., van Knippenberg, F., & Neijt, J. (1990). Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer, 62, 1034–1038.PubMed

11.

Demark-Wahnefried, W., Aziz, N. M., Rowland, J. H., & Pinto, B. M. (2005). Riding the crest of the teachable moment: Promoting long-term health after the diagnosis of cancer. Journal of Clinical Oncology, 23, 5814–5830.PubMedCrossRef

12.

Detmar, S., Aaronson, N., Wever, L., Muller, M., & Schornagel, J. (2000). How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. Journal of Clinical Oncology, 18, 3295–3301.PubMed

13.

Doorduijn, J., Buijt, I., Holt, B., Steijaert, M., Uyl-de Groot, C., & Sonneveld, P. (2005). Self-reported quality of life in elderly patients with aggressive non-Hodgkin’s lymphoma treated with CHOP chemotherapy. European Journal of Haematology, 75, 116–123.PubMedCrossRef

14.

Fernsler, J., & Fanuele, J. S. (1998). Lymphomas: Long-term sequelae and survivorship issues. Seminars in Oncology Nursing, 14, 321–328.PubMedCrossRef

15.

Fisher, S. G., & Fisher, R. I. (2004). The epidemiology of non-Hodgkin’s Lymphoma. Oncogene, 23, 6524–6534.PubMedCrossRef

16.

Ganz, P. A. (2003). Why and how to study the fate of cancer survivors: Observations from the clinic and the research laboratory. European Journal of Cancer, 39, 2136–2141.PubMedCrossRef

17.

Ganz, P., Day, R., Ware, J., Redmond, C., & Fisher, B. (1995). Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. Journal of the National Cancer Institute, 87, 1372–1383.PubMedCrossRef

18.

Ganz, P., Desmond, K., Leedham, B., Rowland, J., Meyerowitz, B., & Belin, T. (2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39–49.PubMed

19.

Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: Understanding women’s health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501–514.PubMed

20.

Goodwin, P. J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., et al. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.PubMedCrossRef

21.

Hamilton, A., Cockburn, M., Chen, X., & Deapen, D. (2005). Factors associated with the use of complementary and alternative medicine by cancer patients in Los Angeles County. Journal of Cancer Integrative Medicine, 3, 51–61.

22.

Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K., et al. (1998). Measurement of fatigue in cancer patients: Development and validation of the fatigue symptom inventory. Quality of Life Research, 7, 301–310.PubMedCrossRef

23.

Hargraves, J., Hays, R., & Cleary, P. (2003). Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 adult core survey. Health Services Research, 38, 1509–1527.PubMedCrossRef

24.

Hawkins, S., Cockburn, M., Hamilton, A., & Mack, T. (2004). An estimate of physical activity prevalence in a large population-based cohort. Medicine and Science in Sports and Exercise, 36, 253–260.PubMedCrossRef

25.

Institute of Medicine (2006). From cancer patient to cancer survivor: Lost in transition. Washington, DC: National Academy.

26.

Jemal, A., Clegg, L. X., Ward, E., Ries, L. A., Wu, X., Jamison, P. M., et al. (2004). Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer, 101, 3–27.PubMedCrossRef

27.

Jerkeman, M., Kaasa, S., Hjermstad, M., Kvaloy, S., & Cavallin-Stahl, E. (2001). Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: A Nordic Lymphoma Group Trial. Medical Oncology, 18, 85–94.PubMedCrossRef

28.

Johnston, L. (1999). Non-Hodgkin’s lymphomas: Making sense of diagnosis, treatment & options. Sebastopol, CA: O’Reilly.

29.

Kessler, T. (1998). The cognitive appraisal of health scale: Development and psychometric evaluation. Research in Nursing & Health, 21, 73–82.CrossRef

30.

Kouroukis, T., Meyer, R., Benger, A., Marcellus, D., Foley, R., & Browman, G. (2004). An evaluation of age-related differences in quality of life preferences in patients with non-Hodgkin’s lymphoma. Leukemia & Lymphoma, 45, 2471–2476.CrossRef

31.

Lazarus, R., & Folkman, S. (1984). Appraisal, stress, and coping. Berlin Heidelberg New York: Springer.

32.

Lee, V., Robin Cohen, S., Edgar, L., Laizner, A. M., & Gagnon, A. J. (2006). Meaning-making intervention during breast or colorectal cancer treatment improves self-esteem, optimism, and self-efficacy. Social Science & Medicine, 62, 3133–3145.CrossRef

33.

Malin, J. L., Ko, C., Ayanian, J. Z., Harrington, D., Nerenz, D. R., Kahn, K. L., et al. (2006). Understanding cancer patients’ experience and outcomes: Development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer, 14, 837–848.PubMedCrossRef

34.

Manne, S., & Glassman, M. (2000). Perceived control, coping efficacy, and avoidance coping as mediators between spouses’ unsupportive behaviors and cancer patients’ psychological distress. Health Psychology, 19, 155–164.PubMedCrossRef

35.

Maunsell, E., Drolet, M., Ouhoummane, N., & Robert, J. (2005). Breast cancer survivors accurately reported key treatment and prognostic characteristics. Journal of Clinical Epidemiology, 58, 364–369.PubMedCrossRef

36.

McCorkle, R., Tang, S. T., Greenwald, H., Holcombe, G., & Lavery, M. (2006). Factors related to depressive symptoms among long term survivors of cervical cancer. Health Care for Women International, 27, 45–58.PubMedCrossRef

37.

National Cancer Institute. Report of the Leukemia, Lymphoma, and Myeloma Progress Review Group. 2001. http://planning.cancer.gov/disease/plans.shtml#prg.

38.

National Center for Health Statistics, Division of Health Interview Statistics: 2000 National Health Interview Survey (NHIS) Public Use Data Release: NHIS Survey Description. Hyattsville, MD, U.S. Department of Health and Human Services, Center for Disease Control and Prevention, March 2002.

39.

Nelson, D. E., Kreps, G. L., Hesse, B. W., Croyle, R. T., Willis, G., Arora, N. K., et al. (2004). The Health Information National Trends Survey (HINTS): Development, design, and dissemination. Journal of Health Communication, 9, 443–460, discussion 81–84.PubMedCrossRef

40.

Pakilit, A. T., Kahn, B. A., Petersen, L., Abraham, L. S., Greendale, G. A., & Ganz, P. A. (2001). Making effective use of tumor registries for cancer survivorship research. Cancer, 92, 1305–1314.PubMedCrossRef

41.

Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The memorial symptom assessment scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A, 1326–1336.PubMedCrossRef

42.

Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson R. A., Penson, D. F., et al. (2004). Five year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. Journal of the National Cancer Institute, 96, 1358–1367.PubMedCrossRef

43.

Potosky, A., Harlan, L., Stanford, J., Gilliland, F., Hamilton, A., Albertsen, P. C., et al. (1999). Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study. Journal of the National Cancer Institute, 91, 1719–1724.PubMedCrossRef

44.

Revicki, D., Sorensen, S., & Wu, A. (1998). Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Medical Care, 36, 126–137.PubMedCrossRef

45.

Robison, L., Mertens, A., Boice, J., Breslow, N., Donaldson, S., Green, D. M., et al. (2002). Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Medical and Pediatric Oncology, 38, 229–239.PubMedCrossRef

46.

Scheier, M., Carver, C., & Bridges, M. (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. Journal of Personality and Social Psychology, 67, 1063–1078.PubMedCrossRef

47.

Sehn, L., & Connors, J. (2005). Treatment of aggressive non-Hodgkin’s lymphoma: A North American perspective. Oncology, 19(Supl 1), 27–34.

48.

Sherbourne, C., & Stewart, A. (1991). The MOS social support survey. Social Science & Medicine, 32, 705–714.CrossRef

49.

Shields, C. G., Morrow, G. R., Griggs, J. J., Mallinger, J., Roscoe, J. A., Wade, J. L., et al. (2004). Decision role preferences of patients receiving adjuvant cancer treatment: A university of Rochester Cancer Center Community Clinical Oncology Program. Supportive Cancer Therapy, 1, 119–126.CrossRefPubMed

50.

Smith, M., Wallston, K., & Smith, C. (1995). The development and validation of the Perceived Health Competence Scale. Health Education Research, 10, 51–64.PubMedCrossRef

51.

Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2, 888–891.PubMedCrossRef

52.

Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA, 283, 354–360.PubMedCrossRef

53.

Stat Bite (2006). Number of cancer survivors by site, 2003. Journal of the National Cancer Institute, 98, 1514.

54.

Stiggelbout, A., de Haes, J., Vree, R., van de Velde, C., Bruijninckx, C., van Groningen, K., et al. (1997). Follow-up of colorectal cancer patients: Quality of life and attitudes towards follow-up. British Journal of Cancer, 75, 914–920.PubMed

55.

Syrjala, K. L., Schroeder, T. C., Abrams, J. R., Atkins, T. Z., Brown, W. S., Sanders, J. E., et al. (2000). Sexual function measurement and outcomes in cancer survivors and matched controls. Journal of Sex Research, 37, 213–225.CrossRef

56.

Tchen, N., Soubeyran, P., Eghbali, H., Ceccaldi, J., Cany, L., Balzon, J. C., et al. (2002). Quality of life in patients with aggressive non-Hodgkin’s lymphoma. Validation of the medical outcomes study short form 20 and the Rotterdam symptom checklist in older patients. Critical Reviews in Oncology/Hematology, 43, 219–226.PubMedCrossRef

57.

The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993). A predictive model for aggressive non-Hodgkin’s lymphoma. NEJM, 329, 987–994.CrossRef

58.

The Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982). National Cancer Institute sponsored study of classifications of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer, 49, 2112–2135.CrossRef

59.

Thirlaway, K., Fallowfield, L., & Cuzick, J. (1996). The sexual activity questionnaire: A measure of women’s sexual functioning. Quality of Life Research, 5, 81–90.PubMedCrossRef

60.

Ware, J. J., Kosinski, M., & Dewey, J. (2000). How to score version 2 of the SF-36® health survey. Lincoln, RI: QualityMetric Incorporated.

61.

Ware, J. J., Kosinski, M., & Gandek, B. (2000). SF-36® Health survey: Manual & interpretation guide. Lincoln, RI: QualityMetric Incorporated.

62.

Wilson, I., & Cleary, P. (1995). Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59–65.PubMedCrossRef

63.

Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E. Jr., Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Medical Care, 29, 786–798.PubMedCrossRef

64.

Zigmond, A., & Snaith, R. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.PubMed

Titel: Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors
verfasst von: Neeraj K. Arora
Ann S. Hamilton
Arnold L. Potosky
Julia H. Rowland
Noreen M. Aziz
Keith M. Bellizzi
Carrie N. Klabunde
Wendy McLaughlin
Jennifer Stevens
Publikationsdatum: 01.03.2007
Verlag: Kluwer Academic Publishers-Plenum Publishers
Erschienen in: Journal of Cancer Survivorship / Ausgabe 1/2007
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-007-0004-3

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Population-based survivorship research using cancer registries: a study of non-Hodgkin’s Lymphoma survivors

Abstract

Introduction

Materials and methods

Results

Conclusions

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Introduction

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Defining cancer survivorship

Preparing professional staff to care for cancer survivors

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study

Age and attachment style impact stress and depressive symptoms among caregivers: a prospective investigation

Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer

Follow-up care for young adult survivors of cancer: lessons from pediatrics

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie